Myocardial energetics in left ventricular hypertrophy

Current Cardiology Reviews

Volumn 5, Issue 3, 2009, Pages 243-250

  Jameel, Mohammad N ^a   Zhang, Jianyi ^a  

^a UNIVERSITY OF MINNESOTA   (United States)

Author keywords

Left ventricular hypertrophy; Myocardial energetic

Indexed keywords

CREATINE KINASE; PHOSPHATE;

ARTERIAL WALL THICKNESS; DRESSLER SYNDROME; ENERGY METABOLISM; ENERGY TRANSFER; GLUCOSE TRANSPORT; GLYCOLYSIS; HEART LEFT VENTRICLE HYPERTROPHY; HEART LEFT VENTRICLE OVERLOAD; HUMAN; NONHUMAN; OXIDATION; OXIDATIVE PHOSPHORYLATION; OXYGENATION; PHOSPHATE BLOOD LEVEL; PHOSPHATE METABOLISM; PRIORITY JOURNAL; REVIEW; SYSTOLIC BLOOD PRESSURE;

EID: 70449644852     PISSN: 1573403X     EISSN: None     Source Type: Journal    
DOI: 10.2174/157340309788970379     Document Type: Review

References (50)

1. Zhang J, Merkle H, Hendrich K, et al. Bioenergetic abnormalities associated with severe left ventricular hypertrophy. J Clin Invest 1993; 92: 993-1003. (Pubitemid 23262424)
2. Bache RJ, Zhang J, Path G, et al. High-energy phosphate responses to tachycardia and inotropic stimulation in left ventricular hypertrophy. Am J Physiol 1994; 266: H1959-70.
3. Massie BM, Schaefer S, Garcia J, et al. Myocardial high-energy phosphate and substrate metabolism in swine with moderate left ventricular hypertrophy. Circulation 1995; 91: 1814-1823
4. Bache RJ, Zhang J, Murakami Y, et al. Myocardial oxygenation at high workstates in hearts with left ventricular hypertrophy. Cardiovasc Res 1999; 42: 616-626 (Pubitemid 29298130)
5. Wyss M, Smeitink J, Wevers RA, Wallimann T. Mitochondrial creatine kinase: a key enzyme of aerobic energy metabolism. Biochim Biophys Acta 1992; 1102: 119-166
6. Ye Y, Wang C, Zhang J, et al. Myocardial creatine kinase kinetics and isoform expression in hearts with severe LV hypertrophy. Am J Physiol Heart Circ Physiol 2001; 281: H376-86.
7. Saupe KW, Spindler M, Hopkins JC, Shen W, Ingwall JS. Kinetic, thermodynamic, and developmental consequences of deleting creatine kinase isoenzymes from the heart. Reaction kinetics of the creatine kinase isoenzymes in the intact heart. J Biol Chem 2000; 275: 19742-19746
8. Vatner DE, Ingwall JS. Effects of moderate pressure overload cardiac hypertrophy on the distribution of creatine kinase isozymes. Proc Soc Exp Biol Med 1984; 175: 5-9.
9. Gong G, Liu J, Liang P, et al. Oxidative capacity in failing hearts. Am J Physiol Heart Circ Physiol 2003; 285: H541-8.
10. Christe ME, Rodgers RL. Altered glucose and fatty acid oxidation in hearts of the spontaneously hypertensive rat. J Mol Cell Cardiol 1994; 26: 1371-1375 (Pubitemid 24335572)
11. Zhang J, Duncker DJ, Ya X, et al. Effect of left ventricular hypertrophy secondary to chronic pressure overload on transmural myocardial 2-deoxyglucose uptake. A 31P NMR spectroscopic study. Circulation 1995; 92: 1274-1283
12. Sorokina N, O'Donnell JM, McKinney RD, et al. Recruitment of compensatory pathways to sustain oxidative flux with reduced carnitine palmitoyltransferase I activity characterizes inefficiency in energy metabolism in hypertrophied hearts. Circulation 2007; 115: 2033-2041
13. Garnier A, Fortin D, Delomenie C, Momken I, Veksler V, Ventura-Clapier R. Depressed mitochondrial transcription factors and oxidative capacity in rat failing cardiac and skeletal muscles. J Physiol 2003; 551: 491-501. (Pubitemid 37121707)
14. Barger PM, Brandt JM, Leone TC, Weinheimer CJ, Kelly DP. Deactivation of peroxisome proliferator-activated receptor-alpha during cardiac hypertrophic growth. J Clin Invest 2000; 105: 1723-1730
15. Sack MN, Rader TA, Park S, Bastin J, McCune SA, Kelly DP. Fatty acid oxidation enzyme gene expression is downregulated in the failing heart. Circulation 1996; 94: 2837-2842 (Pubitemid 26411749)
16. Nascimben L, Ingwall JS, Lorell BH, et al. Mechanisms for increased glycolysis in the hypertrophied rat heart. Hypertension 2004; 44: 662-667 (Pubitemid 39435236)
17. Carabello BA. Models of volume overload hypertrophy. J Card Fail 1996;2:55-64.
18. Kleaveland JP, Kussmaul WG, Vinciguerra T, Diters R, Carabello BA. Volume overload hypertrophy in a closed-chest model of mitral regurgitation. Am J Physiol 1988; 254: H1034-41.
19. Carabello BA, Nakano K, Corin W, Biederman R, Spann JF, Jr. Left ventricular function in experimental volume overload hypertrophy. Am J Physiol 1989; 256: H974-81.
20. Carabello BA, Nakano K, Ishihara K, Kanazawa S, Biederman RW, Spann JF, Jr. Coronary blood flow in dogs with contractile dysfunction due to experimental volume overload. Circulation 1991; 83: 1063-1075
21. Urabe Y, Mann DL, Kent RL, et al. Cellular and ventricular contractile dysfunction in experimental canine mitral regurgitation. Circ Res 1992; 70: 131-147
22. Hansen DE, Cahill PD, DeCampli WM, et al. Valvular-ventricular interaction: importance of the mitral apparatus in canine left ventricular systolic performance. Circulation 1986; 73: 1310-1320
23. Zhang J, Toher C, Erhard M, et al. Relationships between myocardial bioenergetic and left ventricular function in hearts with volume-overload hypertrophy. Circulation 1997; 96: 334-343 (Pubitemid 27298441)
24. Miyamoto T, Takeishi Y, Tazawa S, et al. Fatty acid metabolism assessed by 125I-iodophenyl 9-methylpentadecanoic acid (9MPA) and expression of fatty acid utilization enzymes in volume-overloaded hearts. Eur J Clin Invest 2004;34: 176-181 (Pubitemid 38406631)
25. Opie LH, Commerford PJ, Gersh BJ, Pfeffer MA. Controversies in ventricular remodelling. Lancet 2006; 367: 356-367
26. Zhang J, Wilke N, Wang Y, et al. Functional and bioenergetic consequences of postinfarction left ventricular remodeling in a new porcine model. MRI and 31 P-MRS study. Circulation 1996; 94: 1089-1100
27. Liu J, Wang C, Murakami Y, et al. Mitochondrial ATPase and high-energy phosphates in failing hearts. Am J Physiol Heart Circ Physiol 2001; 281: H1319-26.
28. Gourine AV, Hu Q, Sander PR, et al. Interstitial purine metabolites in hearts with LV remodeling. Am J Physiol Heart Circ Physiol 2004; 286: H677-84.
29. Murakami Y, Zhang Y, Cho YK, et al. Myocardial oxygenation during high work states in hearts with postinfarction remodeling. Circulation 1999;99:942-948 (Pubitemid 29094310)
30. Hoang CD, Zhang J, Payne RM, Apple FS. Post-infarction left ventricular remodeling induces changes in creatine kinase mRNA and protein subunit levels in porcine myocardium. Am J Pathol 1997; 151: 257-264 (Pubitemid 27283976)
31. Murakami Y, Zhang J, Eijgelshoven MH, et al. Myocardial creatine kinase kinetics in hearts with postinfarction left ventricular remodeling. Am J Physiol 1999; 276: H892-900.
32. Remondino A, Rosenblatt-Velin N, Montessuit C, et al. Altered expression of proteins of metabolic regulation during remodeling of the left ventricle after myocardial infarction. J Mol Cell Cardiol 2000; 32: 2025-2034 (Pubitemid 30846461)
33. Rosenblatt-Velin N, Montessuit C, Papageorgiou I, Terrand J, Lerch R. Postinfarction heart failure in rats is associated with upregulation of GLUT-1 and downregulation of genes of fatty acid metabolism. Cardiovasc Res 2001; 52: 407-416 (Pubitemid 33153103)
34. Hu Q, Wang X, Lee J, et al. Profound bioenergetic abnormalities in peri-infarct myocardial regions. Am J Physiol Heart Circ Physiol 2006; 291: H648-57.
35. Feygin J, Hu Q, Swingen C, Zhang J. Relationships between regional myocardial wall stress and bioenergetics in hearts with left ventricular hypertrophy. Am J Physiol Heart Circ Physiol 2008; 294: H2313-21.
36. Conway MA, Allis J, Ouwerkerk R, Niioka T, Rajagopalan B, Radda GK. Detection of low phosphocreatine to ATP ratio in failing hypertrophied human myocardium by 31P magnetic resonance spectroscopy. Lancet 1991; 338: 973-976
37. Lamb HJ, Beyerbacht HP, van der Laarse A, et al. Diastolic dysfunction in hypertensive heart disease is associated with altered myocardial metabolism. Circulation 1999; 99: 2261-2267 (Pubitemid 29201132)
38. Smith CS, Bottomley PA, Schulman SP, Gerstenblith G, Weiss RG. Altered creatine kinase adenosine triphosphate kinetics in failing hypertrophied human myocardium. Circulation 2006; 114: 1151-1158 (Pubitemid 44386479)
39. Conway MA, Bottomley PA, Ouwerkerk R, Radda GK, Rajagopalan B. Mitral regurgitation: impaired systolic function, eccentric hypertrophy, and increased severity are linked to lower phosphocreatine/ATP ratios in humans. Circulation 1998; 97: 1716-1723 (Pubitemid 28211421)
40. Neubauer S, Krahe T, Schindler R, et al. 31P magnetic resonance spectroscopy in dilated cardiomyopathy and coronary artery disease. Altered cardiac high-energy phosphate metabolism in heart failure. Circulation 1992; 86: 1810-1818
41. Neubauer S, Horn M, Cramer M, et al. Myocardial phosphocreatine-to-ATP ratio is a predictor of mortality in patients with dilated cardiomyopathy. Circulation 1997; 96: 2190-2196 (Pubitemid 27425822)
42. Beer M, Seyfarth T, Sandstede J, et al. Absolute concentrations of high-energy phosphate metabolites in normal, hypertrophied, and failing human myocardium measured noninvasively with (31)PSLOOP magnetic resonance spectroscopy. J Am Coll Cardiol 2002; 40: 1267-1274
43. Nascimben L, Ingwall JS, Pauletto P, et al. Creatine kinase system in failing and nonfailing human myocardium. Circulation 1996; 94: 1894-1901 (Pubitemid 26349302)
44. Beer M, Spindler M, Sandstede JJ, et al. Detection of myocardial infarctions by acquisition-weighted 31P-MR spectroscopy in humans. J Magn Reson Imaging 2004; 20: 798-802. (Pubitemid 39426075)
45. Weiss RG, Bottomley PA, Hardy CJ, Gerstenblith G. Regional myocardial metabolism of high-energy phosphates during isometric exercise in patients with coronary artery disease. N Engl J Med 1990; 323: 1593-1600
46. Yabe T, Mitsunami K, Inubushi T, Kinoshita M. Quantitative measurements of cardiac phosphorus metabolites in coronary artery disease by 31P magnetic resonance spectroscopy. Circulation 1995; 92: 15-23.
47. Paolisso G, Gambardella A, Galzerano D, et al. Total-body and myocardial substrate oxidation in congestive heart failure. Metabolism 1994; 43: 174-179 (Pubitemid 24061849)
48. Taylor M, Wallhaus TR, Degrado TR, et al. An evaluation of myocardial fatty acid and glucose uptake using PET with [18F]fluoro-6-thia-heptadecanoic acid and [18F]FDG in Patients with Congestive Heart Failure. J Nucl Med 2001; 42: 55-62. (Pubitemid 32104778)
49. Davila-Roman VG, Vedala G, Herrero P, et al. Altered myocardial fatty acid and glucose metabolism in idiopathic dilated cardiomyopathy. J Am Coll Cardiol 2002; 40: 271-277 (Pubitemid 34756287)
50. Stanley WC, Recchia FA, Lopaschuk GD. Myocardial substrate metabolism in the normal and failing heart. Physiol Rev 2005; 85:1093-1129 (Pubitemid 40894649)